419 results on '"Popoli, Patrizia"'
Search Results
2. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
3. Early access programs for medicines: a reform proposal for the Italian National Health Service
4. Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review
5. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
6. Adenosine Receptors and Neuroinflammation
7. What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?
8. Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice
9. Functional Interaction between Adenosine A2A and mGlu5 Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu5R Binding in Mouse Hippocampus and Neuroblastoma Cell Line
10. Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice
11. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
12. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
13. Synergistic Interaction between Adenosine A2A and Glutamate mGlu5 Receptors: Implications for Striatal Neuronal Function
14. Branched Chain Amino Acids in Experimental Models of Amyotrophic Lateral Sclerosis
15. Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington’s disease
16. Adenosine A2A receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes
17. Functional Interaction between Adenosine A 2A and mGlu 5 Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu 5 R Binding in Mouse Hippocampus and Neuroblastoma Cell Line.
18. Adenosine Receptors in Huntington’s Disease
19. Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
20. List of Contributors
21. Control of Motor Function by Adenosine A 2A Receptors in Parkinson’s and Huntington’s Disease
22. Neuronal vs Glial Cell Contribution to Adenosine A 2A Receptor-Induced Neurodegeneration
23. Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
24. Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA
25. Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
26. Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021
27. Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study
28. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
29. Striatal adenosine–cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors
30. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences
31. Molecular tests and target therapies in oncology: recommendations from the Italian workshop
32. Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons
33. Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
34. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial
35. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease
36. Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A2A Receptor-Mediated Effects in the Central Nervous System
37. Additional file 1 of Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
38. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
39. P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease
40. Adenosine Receptors in Huntington’s Disease
41. Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1
42. BDNF prevents NMDA-induced toxicity in models of Huntingtonʼs disease: the effects are genotype specific and adenosine A2A receptor is involved
43. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
44. Role of Adenosine in the Basal Ganglia
45. Contributors
46. Complex behavioral and synaptic effects of dietary branched chain amino acids in a mouse model of amyotrophic lateral sclerosis
47. Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission
48. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
49. Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trial
50. Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinsonʼs disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.